Highlights

  • Race and social determinants of health were associated with the likelihood of undergoing kidney transplantation among US adults with kidney failure.
  • Interventions that target social determinants of health may improve access to kidney transplantation.

Newswise — Washington, DC (January 28, 2021) — Among US adults with kidney failure, race and social determinants of health were associated with patients’ likelihood of receiving a kidney transplant. The findings come from an analysis that will appear in an upcoming issue of CJASN.

Blacks are more likely than whites to develop kidney failure, but they’re less likely to undergo kidney transplantation, the optimal treatment for kidney failure. Blacks also have disproportionately lower rates of kidney transplants from living donors, which offer superior patient and transplant survival rates compared with deceased-donor kidney transplants.

To assess whether social determinants of health—such as demographics, cultural factors, psychosocial characteristics, and transplant knowledge—may play a role in these disparities, Larissa Myaskovsky, PhD (University of New Mexico Health Sciences Center) and her colleagues prospectively followed 1,056 patients referred for kidney transplantation from 2010 to 2012 (with follow up through 2018) at the University of Pittsburgh Medical Center. Patients completed an interview soon after their initial kidney transplant evaluation and were followed until their kidney transplants was performed.

The team found that even after accounting for social determinants of health, Blacks had a lower likelihood of receiving a kidney transplant overall, and specifically a living-donor transplant but not deceased-donor transplant.

Black race, older age, lower income, public insurance, more comorbidities, being transplanted before 2014 kidney allocation policy changes, greater religiosity, less social support, less transplant knowledge, and fewer learning activities each were associated with a lower probability of receiving a kidney transplant.

“Our data suggest a critical need for transplant centers to identify and intervene on social determinants for at-risk populations,” said Dr. Myaskovsky. “Based on our findings, developing interventions that target patients with low transplant knowledge, religious objection to living-donor transplant, or poor social support may enhance equal access to kidney transplantation because transplant teams can use these risk factors to target patients who may need more support to ensure they receive a transplant.”

An accompanying Patient Voice editorial provides the perspective of a Black American woman who was suddenly diagnosed with kidney failure 7 years ago at the age of 49 years. She is a kidney transplant recipient and also the Director of Outreach and Government Relations for the National Kidney Foundation of Illinois. 

Study co-authors include Hannah Wesselman, BS, C. Graham Ford, MS, Yuridia Leyva, MS, Xingyuan Li, PhD, Chung-Chou H. Chang, PhD, Mary Amanda Dew, PhD, Kellee Kendall, MS, Emilee Croswell, BA, John R. Pleis, PhD, Yue Harn Ng, MD, Mark L. Unruh, MD, and Ron Shapiro, MD.

Disclosures: This work was funded in part by Grant Number R01DK081325 from the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK), Grant Number UL1 TR001857 from the National Center for Advancing Translational Sciences (NCATS), and Grant Number DCI C-3924 from Dialysis Clinic Inc. (DCI), a national non-profit dialysis provider.

The article, titled “Social Determinants of Health and Race Disparities in Kidney Transplant,” will appear online at http://cjasn.asnjournals.org/ on January 28, 2021, doi: 10. 2215/CJN.0486042.

The Patient Voice editorial, title” Barriers to Kidney Transplantation in Racial/Ethnic Minorities,” will appear online at http://cjasn.asnjournals.org/ on January 28, 2021, doi: 10.2215/CJN.19371220.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit www.asn-online.org.

 

# # #

 

SEE ORIGINAL STUDY